Pfizer shows less immunity to Delta variant of coronavirus: Lancet study



People fully vaccinated with the Pfizer-BioNTech vaccine are likely to have more than five times lower levels of neutralising antibodies against the Delta variant first identified in India compared to the original strain, according to research published in The Lancet journal.

► Subscribe to The Economic Times for latest video updates. It’s free! – http://www.youtube.com/TheEconomicTimes?sub_confirmation=1

► More Videos @ ETTV – http://economictimes.indiatimes.com/TV

► http://EconomicTimes.com

► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp

Follow ET on:

► Facebook – https://www.facebook.com/EconomicTimes
► Twitter – http://www.twitter.com/economictimes
► LinkedIn – http://www.linkedin.com/company/economictimes
► Instagram – https://www.instagram.com/the_economic_times
► Flipboard – https://flipboard.com/@economictimes

source